Novartis Bioventures Ltd Bicycle Therapeutics PLC (BCYC) insider trading activity

Novartis Bioventures LTD is > 10% Shareholder of BICYCLE THERAPEUTICS plc. Currently has a direct ownership of 1.77 Million shares of BCYC, which is worth approximately $42.5 Million. The most recent transaction as insider was on May 28, 2019, when has been sold 1,529,561 shares (Ordinary Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.77M

0% 3M change

0% 12M change

Total Value Held $42.5 Million

Novartis Bioventures Ltd Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 28 2019	BUY Conversion of derivative security	-	1,529,561 Added 48.86%	1,601,011 Ordinary Shares
May 28 2019	BUY Open market or private purchase	$2,360,820 $14.0 p/Share	168,630 Added 8.7%	1,769,641 Ordinary Shares
May 28 2019	BUY Exercise of in-the-money or at-the-money derivatives securities	-	71,450 Added 6.9%	964,645 Ordinary Shares

Also insider at

ATRX

Adhera Therapeutics, Inc. Healthcare

> 10% Shareholder

ELDN

Eledon Pharmaceuticals, Inc. Healthcare

> 10% Shareholder

YMTX

YUMANITY THERAPEUTICS, INC. Healthcare

> 10% Shareholder

AGLE

Aeglea BioTherapeutics, Inc. Healthcare

RARX

Ra Pharmaceuticals, Inc.

> 10% Shareholder

AADI

Aadi Bioscience, Inc. Healthcare

> 10% Shareholder

ALRN

AILERON THERAPEUTICS INC Healthcare

> 10% Shareholder

ALT

Altimmune, Inc. Healthcare

> 10% Shareholder

GRTX

Galera Therapeutics, Inc. Healthcare

AKUS

Akouos, Inc. Healthcare

NBL